logo

FDA Calendar

Share
PDUFA dates and FDA Panel Review dates are very important because they are make or break events for biostocks when the decisions are announced. Also, usually biostocks experience a run-up going into the scheduled decision/review dates. So having prior knowledge of the catalysts goes a long way toward maximizing profit or minimizing loss while trading volatile biotech stocks.
Listed below are large cap, mid cap and small cap stocks with pending regulatory catalysts.

Get in-depth analysis and insight on investing in the high-stakes biotech and pharma sectors. Check out our premium biotech research product and our biotech home page.
Company Name
Ticker
Drug
Event
Date
Outcome
Details
Regeneron Pharmaceuticals
Dupixent (sBLA)
FDA decision on Dupixent as an add-on maintenance treatment for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
05/26/2020
PTC Therapeutics Inc.
Risdiplam (NDA)
FDA decision on Risdiplam for the treatment of spinal muscular atrophy
05/24/2020
Roche Holding AG
Risdiplam (NDA)
FDA decision on risdiplam for spinal muscular atrophy
05/24/2020
Sumitomo Dainippon Pharma
Dasotraline (NDA)
FDA decision on Dasotraline for the treatment of patients with moderate-to-severe binge eating disorder
05/14/2020
Blueprint Medicines
Avapritinib (NDA)
FDA decision on Avapritinib for the treatment of adult patients with fourth-line gastrointestinal stromal tumor (GIST)
05/14/2020
Halozyme Therapeutics, Inc.
DARZALEX (BLA)
FDA decision on subcutaneous delivery of DARZALEX for patients with multiple myeloma.
05/12/2020
Sanofi
Isatuximab (BLA)
FDA decision on Isatuximab b for the treatment of patients with relapsed/refractory multiple myeloma
04/30/2020
United Therapeutics Corp
Trevyent (UTHR)
FDA decision on Trevyent for the treatment of pulmonary arterial hypertension
04/27/2020
Correvio Pharma Corp.
Trevyent (NDA)
FDA decision on Trevyent for the treatment of pulmonary arterial hypertension
04/27/2020
Neurocrine Biosciences Inc
Opicapone (NDA)
FDA decision on Opicapone as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes.
04/26/2020
Sanofi
MenQuadfi (BLA)
FDA decision on MenQuadfi to prevent meningococcal meningitis
04/25/2020
AstraZeneca PLC
AZN.L, AZN
Trastuzumab deruxtecan (BLA)
FDA decision on Trastuzumab deruxtecan or treatment of patients with HER2-positive metastatic breast cancer
04/17/2020
Eli Lilly And Co.
Empagliflozin/Iinagliptin/Metformin Triple Combination Tablet (NDA)
FDA decision on the triple combination tablet for adults with Type 2 Diabetes
04/04/2020
FDA approves Trijardy XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets) on Jan 27, 2020
Bristol-Myers Squibb Co.
Luspatercept (BLA)
FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
04/04/2020
Acceleron Pharma, Inc
Luspatercept (BLA)
FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
04/04/2020
Buy this Content


pharma-051017_19feb20.jpg Today's Daily Dose brings you news about Adamis Pharma's upcoming regulatory catalyst, the delay in FDA decision related to Eton Pharma's drug candidate, the global license agreement between Five Prime and Seattle Genetics, and Karyopharm's date with FDA.
Myomo Inc. (MYO), a wearable medical robotics company, has signed a nationwide payer agreement with HOMELINK, an expert in orthotic and prosthetic reimbursement.
pharma-010919_19feb20.jpg Today's Daily Dose brings you news about BioCryst Pharma's upcoming regulatory event, Brickell Biotech clearing legal uncertainty related to its lead asset, Bellerophon's phase IIb data of INOPulse, and progress on Lurbinectedin NDA.
Read More
MediPharm Labs Corp., a Canada-based provider of cannabis oil and concentrates, said Thursday that it has entered into an agreement to supply medical cannabis products to Medical Cannabis by Shoppers, the online platform of Canadian pharmacy chain Shoppers Drug Mart. According to MediPharm Labs,...
California-based cannabis company Hollister Biosciences Inc. recently announced that it entered into a licensing agreement with actor and cannabis icon Tommy Chong to manufacture and distribute a cannabis tincture. The tincture, branded Tommy Chong's Cannabis Full Spectrum Elixir 1:1, features a...
Canadian marijuana company Invictus MD Strategies Corp. said Thursday that the Supreme Court of British Columbia has granted the company creditor protection under the Companies' Creditors Arrangement Act or CCAA. The court order also extends protection to Greener Pastures MD Ltd., Acreage Pharms Ltd....
Read More
>